Mirela Ionescu

5.0k total citations · 1 hit paper
52 papers, 4.0k citations indexed

About

Mirela Ionescu is a scholar working on Rheumatology, Pharmacology and Surgery. According to data from OpenAlex, Mirela Ionescu has authored 52 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Rheumatology, 16 papers in Pharmacology and 12 papers in Surgery. Recurrent topics in Mirela Ionescu's work include Osteoarthritis Treatment and Mechanisms (39 papers), Inflammatory mediators and NSAID effects (16 papers) and Cell Adhesion Molecules Research (11 papers). Mirela Ionescu is often cited by papers focused on Osteoarthritis Treatment and Mechanisms (39 papers), Inflammatory mediators and NSAID effects (16 papers) and Cell Adhesion Molecules Research (11 papers). Mirela Ionescu collaborates with scholars based in Canada, United States and Romania. Mirela Ionescu's co-authors include A. Robin Poole, A. Robin Poole, A Reiner, R. Clark Billinghurst, Leif Dahlberg, Harold Van Wart, Roger Bourne, C H Rorabeck, Sheila Laverty and Peter G. Mitchell and has published in prestigious journals such as Journal of Clinical Investigation, American Journal of Respiratory and Critical Care Medicine and Annals of the Rheumatic Diseases.

In The Last Decade

Mirela Ionescu

49 papers receiving 3.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage.

1997 800 citations R. Clark Billinghurst, Leif Dahlberg et al. Journal of Clinical Investigation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mirela Ionescu Canada	34	3.1k	985	927	707	592	52	4.0k
R. Clark Billinghurst United States	25	1.9k 0.6×	848 0.9×	542 0.6×	951 1.3×	660 1.1×	34	3.4k
Sanshiro Hashimoto United States	26	2.4k 0.8×	867 0.9×	720 0.8×	432 0.6×	980 1.7×	44	3.7k
Ada A. Cole United States	29	1.8k 0.6×	720 0.7×	433 0.5×	535 0.8×	467 0.8×	44	2.7k
Ginette Tardif Canada	33	1.9k 0.6×	376 0.4×	795 0.9×	746 1.1×	1.1k 1.8×	53	3.2k
Pascal Reboul France	34	1.6k 0.5×	481 0.5×	765 0.8×	523 0.7×	1.0k 1.8×	86	3.3k
Arjen B. Blom Netherlands	38	3.0k 1.0×	621 0.6×	949 1.0×	488 0.7×	1.9k 3.2×	93	4.8k
Stephen L. Myers United States	27	1.3k 0.4×	882 0.9×	323 0.3×	136 0.2×	788 1.3×	48	2.9k
W. B. Van Den Berg Netherlands	20	1.7k 0.6×	385 0.4×	517 0.6×	341 0.5×	817 1.4×	42	2.6k
Xavier Houard France	35	1.2k 0.4×	894 0.9×	440 0.5×	502 0.7×	889 1.5×	67	3.6k
André Struglics Sweden	25	1.3k 0.4×	694 0.7×	313 0.3×	262 0.4×	448 0.8×	80	2.0k

Countries citing papers authored by Mirela Ionescu

Since Specialization

Citations

This map shows the geographic impact of Mirela Ionescu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mirela Ionescu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mirela Ionescu more than expected).

Fields of papers citing papers by Mirela Ionescu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mirela Ionescu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mirela Ionescu. The network helps show where Mirela Ionescu may publish in the future.

Co-authorship network of co-authors of Mirela Ionescu

This figure shows the co-authorship network connecting the top 25 collaborators of Mirela Ionescu. A scholar is included among the top collaborators of Mirela Ionescu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mirela Ionescu. Mirela Ionescu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ciocîrlan, Mihai, Rodica Gincul, Vincent Lépilliez, et al.. (2012). Non-Barrett's esophageal and gastric tumors: diagnosis and treatment. Gastrointestinal Endoscopy. 76(3). 501–505.

Conrozier, Thierry, François‐Régis Ferrand, A. Robin Poole, et al.. (2006). Differences in biomarkers of type II collagen in atrophic and hypertrophic osteoarthritis of the hip: implications for the differing pathobiologies. Osteoarthritis and Cartilage. 15(4). 462–467. 22 indexed citations

Verstappen, Suzanne, et al.. (2006). Radiographic joint damage in rheumatoid arthritis is associated with differences in cartilage turnover and can be predicted by serum biomarkers: an evaluation from 1 to 4 years after diagnosis. Arthritis Research & Therapy. 8(1). R31–R31. 52 indexed citations

Yasuda, Tadashi, Elena V. Tchetina, Peter J. Roughley, et al.. (2006). Peptides of type II collagen can induce the cleavage of type II collagen and aggrecan in articular cartilage. Matrix Biology. 25(7). 419–429. 40 indexed citations

Kim, Tae‐Hwan, Millicent Stone, Xiang Zhang, et al.. (2005). Cartilage biomarkers in ankylosing spondylitis: Relationship to clinical variables and treatment response. Arthritis & Rheumatism. 52(3). 885–891. 45 indexed citations

Girard, Christiane, Luc Chouinard, John S. Sampalis, et al.. (2005). Effect of oral glucosamine on cartilage degradation in a rabbit model of osteoarthritis. Arthritis & Rheumatism. 52(4). 1118–1128. 101 indexed citations

King, Lindsay, et al.. (2004). Biomarkers differentiate axial and peripheral disease in Ankylosing Spondylitis, and reflect response to infliximab. Arthritis & Rheumatism. 50(9). 1 indexed citations

Matyas, John R., Lynne Atley, Mirela Ionescu, David R. Eyre, & A. Robin Poole. (2004). Analysis of cartilage biomarkers in the early phases of canine experimental osteoarthritis. Arthritis & Rheumatism. 50(2). 543–552. 132 indexed citations

Billinghurst, R. Clark, Mirela Ionescu, & A. Robin Poole. (2003). Immunoassay for Collagenase-Mediated Cleavage of Types I and II Collagens. Humana Press eBooks. 151. 457–472. 8 indexed citations

10.

Fraser, Alexander, Ursula Fearon, R. Clark Billinghurst, et al.. (2003). Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: Relationship to mediators of systemic and local inflammation. Arthritis & Rheumatism. 48(11). 3085–3095. 109 indexed citations

11.

Chu, Qili, Mandi J. Lopez, Kei Hayashi, et al.. (2002). Elevation of a collagenase generated type II collagen neoepitope and proteoglycan epitopes in synovial fluid following induction of joint instability in the dog. Osteoarthritis and Cartilage. 10(8). 662–669. 70 indexed citations

12.

Marcoux, M., et al.. (2001). Use of synovial fluid markers of cartilage synthesis and turnover to study effects of repeated intra‐articular administration of methylprednisolone acetate on articular cartilage in vivo. Journal of Orthopaedic Research®. 19(2). 250–258. 41 indexed citations

13.

Ishiguro, Naoki, Takayasu Ito, Takeshi Oguchi, et al.. (2001). Relationships of matrix metalloproteinases and their inhibitors to cartilage proteoglycan and collagen turnover and inflammation as revealed by analyses of synovial fluids from patients with rheumatoid arthritis. Arthritis & Rheumatism. 44(11). 2503–2511. 64 indexed citations

14.

Dahlberg, Leif, R. Clark Billinghurst, Paul Manner, et al.. (2000). Selective enhancement of collagenase-mediated cleavage of resident type II collagen in cultured osteoarthritic cartilage and arrest with a synthetic inhibitor that spares collagenase 1 (matrix metalloproteinase 1). Arthritis & Rheumatism. 43(3). 673–673. 190 indexed citations

15.

Otterness, Ivan G., et al.. (2000). An analysis of 14 molecular markers for monitoring osteoarthritis: segregation of the markers into clusters and distinguishing osteoarthritis at baseline. Osteoarthritis and Cartilage. 8(3). 180–185. 92 indexed citations

16.

Billinghurst, R. Clark, William Ka Kei Wu, Mirela Ionescu, et al.. (2000). Comparison of the degradation of type II collagen and proteoglycan in nasal and articular cartilages induced by interleukin-1 and the selective inhibition of type II collagen cleavage by collagenase. Arthritis & Rheumatism. 43(3). 664–664. 135 indexed citations

17.

Armstrong, Lynne, David Thickett, J.P. Mansell, et al.. (1999). Changes in Collagen Turnover in Early Acute Respiratory Distress Syndrome. American Journal of Respiratory and Critical Care Medicine. 160(6). 1910–1915. 54 indexed citations

18.

Frisbie, David D., et al.. (1999). Measurement of synovial fluid and serum concentrations of the 846 epitope of chondroitin sulfate and of carboxy propeptides of type II procollagen for diagnosis of osteochondral fragmentation in horses. American Journal of Veterinary Research. 60(3). 306–309. 61 indexed citations

19.

Lohmander, Stefan, et al.. (1999). Changes in joint cartilage aggrecan after knee injury and in osteoarthritis. Arthritis & Rheumatism. 42(3). 534–544. 195 indexed citations

20.

Poole, A. Robin, Mirela Ionescu, A Swan, & Paul Dieppe. (1994). Changes in cartilage metabolism in arthritis are reflected by altered serum and synovial fluid levels of the cartilage proteoglycan aggrecan. Implications for pathogenesis.. Journal of Clinical Investigation. 94(1). 25–33. 137 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact